PERSPECTA

News from every angle

← Back to headlines

FDA Panel Supports Broader Access to Peptides, Including BPC-157

An FDA advisory committee has voted to recommend adding the popular peptide BPC-157 to the drug compounding list, a move that supports broader public access to peptides like the so-called Wolverine peptide despite scientist objections and warnings about risks.

23 Jul, 20:12 — 23 Jul, 20:12
PostShare

Sources

Showing 1 of 2 sources
FTVery High23d ago

FDA panel supports access to peptides over scientist objections

Vote is first step in broadening public access to so-called Wolverine peptide despite warnings about risks

Read full article →

Coverage Timeline

First report: Yahoo · 23 Jul, 18:32Full coverage: 2 · 2hWindow: 2h
Left-leaningCenterRight-leaning
Yahoo23 Jul, 18:32First to report

FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list

2h later
FT23 Jul, 20:12Latest update

FDA panel supports access to peptides over scientist objections

Related Stories

Dolly Parton Misses Dollywood Event Due to Health Issues, Fans Concerned

1h ago

Supermarkets including Spar, Dirk and Plus warn of undercooked chicken thigh skewers

10h ago

Bengaluru Engineer Kills Wife, Dies by Suicide

10h ago

Motorcyclist in his 30s killed in single-vehicle collision in Co Galway

14h ago